Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.
Atrial fibrillation is a common arrhythmia that is hereditary in a small subgroup of patients. In a family with 11 clinically affected members, we mapped an atrial fibrillation locus to chromosome 1p36-p35 and identified a heterozygous frameshift mutation in the gene encoding atrial natriuretic peptide. Circulating chimeric atrial natriuretic peptide (ANP) was detected in high concentration in subjects with the mutation, and shortened atrial action potentials were seen in an isolated heart model, creating a possible substrate for atrial fibrillation. This report implicates perturbation of the atrial natriuretic peptide-cyclic guanosine monophosphate (cGMP) pathway in cardiac electrical instability.
Hodgson-Zingman
Denice M
DM
Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, USA.
Karst
Margaret L
ML
Zingman
Leonid V
LV
Heublein
Denise M
DM
Darbar
Dawood
D
Herron
Kathleen J
KJ
Ballew
Jeffrey D
JD
de Andrade
Mariza
M
Burnett
John C
JC
Olson
Timothy M
TM
D000200:Action Potentials; D000328:Adult; D000818:Animals; D001281:Atrial Fibrillation / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D009320:Atrial Natriuretic Factor / Q000235:genetics* / Q000378:metabolism; D002874:Chromosome Mapping; D002878:Chromosomes, Human, Pair 1; D004252:DNA Mutational Analysis; D005260:Female; D016368:Frameshift Mutation; D006157:Guanosine Monophosphate / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D015398:Signal Transduction; D044465:White People / Q000235:genetics
D006157:Guanosine Monophosphate; D009320:Atrial Natriuretic Factor